Clinical Trial Update: Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherapy

View source ↗

Summary

Observational studies are being conducted to evaluate the use of bevacizumab in HER2-negative breast cancer treated with neoadjuvant chemotherapy. Sponsor: LiNa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: LiNanlin,Ph.D, Chief Physician,Clinical Professor | Conditions: Breast Cancer, Bevacizumab | Status: UNKNOWN